Table 1.
Clinical data of children at baseline visit.
| Control | Age (years) | Gender | Skinprick test | FEV1% | VitD3 supplement* | Months breastfed |
|---|---|---|---|---|---|---|
| Mean | 4·73 |
Female = 41% Male = 59% |
neg = 90% pos = 10% |
106·9 |
Yes = 36·4% No = 63·6% |
5·84 |
| s.e.m. | 0·18 | 2·67 | 0·88 |
| Asthma | Age (years) | Gender | Asthma severity† | Phenotype‡ | Skin prick test | FEV1% | Treatment | Vitamin D3 supplement* | Months breastfed |
|---|---|---|---|---|---|---|---|---|---|
| Mean | 4·92 |
f = 37·5% m = 62·5% |
I = 62·5% II = 29·2% III = 8·3% |
v+m = 70% u = 16·7% a = 4·2% e = 8·3% |
neg = 15% pos = 85% |
102·75 |
Non‐steroid = 20·9% Steroid = 79·1% |
Yes = 20·8% No = 79·2% |
8·56 |
| s.e.m. | 0·15 | 4·04 | 1·69 |
*Vitamin D3 (VitD3) supplement: Vigantolette, Fluorette. †I = intermittent: forced expiratory volume in 1 s (FEV1) > 80%; MEF > 65%; symptom‐free interval > 2 months; II = mild persistent: FEV1 > 80%; MEF > 65%; symptom‐free interval < 2 months; III = moderate persistent: FEV1 < 80%; MEF < 65%; symptoms several days a week; IV = severe persistent: FEV1 < 60%; symptoms during the day and night; ‡v = virus‐induced; a = allergen‐induced; e = exercise‐induced; u = unresolved; m = mixed (including virus‐induced).